eCardio Diagnostics   Report issue

For profit Phase 4
Founded: Houston TX United States (2004)
Status: Left NME R&D (2007)

Organization Overview

First Clinical Trial
2007
NCT00552084
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (1)

fish oil (Omegavan) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrial Fibrillation (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1